University

• Development of common signatures of infected eucaryotic cells; use of cell-division proteins as broad-spectrum antibacterial targets; development of drugs against bioengineered biological warfare bacteria; use of gene-based broad-spectrum antimicrobial agents; and identification of novel targets that enhance pathogen vulnerability and neutralisation

• Use of insect vectors as early warning systems e.g. detection of chemical signals by parasitic wasps, exploitation of arthropod interaction with biomolecular stimuli, and engineered bee-colonies for detection of harmful of biowarfare agents

• Determination of structural biology of Toxins, development of vaccines and potent toxoids, and rapid genetic identification of Gram-positive pathogens

• Development of protein-based protective agents; invasive intracellular antibiotics, identification of common target inRNA viruses; disruption of cell transport with non-peptide antiviral agents; and rapid drug responses to biological warfare and bioterrorism without loss in potency and effectiveness during stockpiled storage